Point72 Asia (Singapore) Pte. Ltd. Moderna, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,506 shares of MRNA stock, worth $742,472. This represents 0.25% of its overall portfolio holdings.
Number of Shares
22,506Holding current value
$742,472% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
917Shares Held
255MCall Options Held
19.2MPut Options Held
24.7M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.33 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.28 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$843 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$580 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$241 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...